Back

Cardiometabolic multimorbidity and associated risk factors in a cohort identified through community-based screening in Eastern Nepal.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk: lessons from epidemiology Secondary Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sanjib Kumar Sharma

B P Koirala Institute of Health Siences, Dharan (Nepal)

7 More presentations in this session

Presentation thumbnail
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort
Doctor M. Sengelov (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Associations of omega-3 fatty acid subclasses with cardiovascular diseases in 500,000 individuals
Doctor J. Barrett (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
An epidemiological update on infective endocarditis: a two-decade retrospective longitudinal analysis
Doctor K. Madan (London, GB)
Abstract Slides Video
Presentation thumbnail
Systolic blood pressure time in target range and cardiovascular disease and premature death
Mr X. Han (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Association of cumulative systolic blood pressure load with cardiovascular events in patients undergoing percutaneous coronary intervention
Assistant Professor B. Kim (Guri, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular risk: lessons from epidemiology

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Risk factors for cardiometabolic multimorbidity: an analysis of 4 million participants from May Measurement Month 2017-2019
thumbnail
Congress Presentation
Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction
thumbnail
Congress Presentation
Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources